Senseonics Holdings Inc (SENS)
0.3388
0.00 (0.00%)
USD |
NYAM |
Nov 05, 14:32
Senseonics Holdings Debt to Equity Ratio: 91.43 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 91.43 |
| March 31, 2024 | 2.737 |
| December 31, 2023 | 1.151 |
| September 30, 2023 | 0.7776 |
| June 30, 2023 | 0.7444 |
| March 31, 2023 | 0.5814 |
| December 31, 2022 | -27.94 |
| September 30, 2022 | -6.420 |
| June 30, 2022 | 4.110 |
| March 31, 2022 | -0.7075 |
| December 31, 2021 | -0.3381 |
| September 30, 2021 | -0.2335 |
| June 30, 2021 | -0.1933 |
| March 31, 2021 | -0.3124 |
| December 31, 2020 | -0.4193 |
| September 30, 2020 | -1.089 |
| June 30, 2020 | -1.545 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.313 |
| December 31, 2019 | -13.36 |
| September 30, 2019 | 3.562 |
| June 30, 2019 | 3.145 |
| March 31, 2019 | 1.122 |
| December 31, 2018 | 0.9539 |
| September 30, 2018 | 0.6851 |
| June 30, 2018 | 0.5116 |
| March 31, 2018 | -4.254 |
| December 31, 2017 | 3.360 |
| September 30, 2017 | 1.092 |
| June 30, 2017 | 2.011 |
| March 31, 2017 | -1.430 |
| December 31, 2016 | -3.909 |
| September 30, 2016 | 3.468 |
| June 30, 2016 | 1.011 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-27.94
Minimum
Dec 2022
91.43
Maximum
Jun 2024
2.508
Average
-0.3124
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.3764 |
| DexCom Inc | 1.233 |
| Baxter International Inc | 1.688 |
| Boston Scientific Corp | 0.5254 |
| Perspective Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 111.56M |
| Total Liabilities (Quarterly) | 110.98M |
| Shareholders Equity (Quarterly) | 0.578M |
| Current Ratio | 3.111 |
| Net Debt Paydown Yield | -1.44% |